Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 64214-60-4 | MDL No. : | MFCD11847426 |
Formula : | C7H15NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KUDRBYBWCRNGBJ-UHFFFAOYSA-N |
M.W : | 145.20 | Pubchem ID : | 11446410 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.86 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 39.68 |
TPSA : | 29.54 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.36 cm/s |
Log Po/w (iLOGP) : | 2.22 |
Log Po/w (XLOGP3) : | 1.17 |
Log Po/w (WLOGP) : | 1.05 |
Log Po/w (MLOGP) : | 1.15 |
Log Po/w (SILICOS-IT) : | 0.04 |
Consensus Log Po/w : | 1.13 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.28 |
Solubility : | 7.63 mg/ml ; 0.0526 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.39 |
Solubility : | 5.97 mg/ml ; 0.0411 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.87 |
Solubility : | 19.7 mg/ml ; 0.136 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.73 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | Stage #1: at 0℃; for 0.166667 h; Stage #2: With phosphorus trichloride In toluene at 20 - 60℃; for 0.5 h; |
General procedure: A solution of NHMe(OMe) (0.360 g, 6.0 mmol) and benzoic acid (0.244 g, 2.0 mmol) was stirred in dry toluene (10 mL) at 0 °C for 10 min. A solution of PCl3 (0.137 g, 1.0 mmol) in dry toluene (2 mL) was then added dropwise to the mixture. The mixture was warmed to r.t. slowly and then stirred at 60 °C for 0.5 h. When the reaction was complete (TLC monitoring), the mixture was cooled to r.t. The mixture was then quenched with sat. NaHCO3 soln (20 mL) and extracted with EtOAc (3 × 10 mL). The combined organic layers were dried (anhyd MgSO4). The solvent was removed in vacuo.The product was purified by column chromatography (silica gel, petroleum ether–EtOAc, 3:2) to give pure 3a as a colorless oil; yield: 320 mg (97percent). |
[ 113778-69-1 ]
N-Methoxy-N-methylisobutyramide
Similarity: 0.97
[ 104863-65-2 ]
N-Methoxy-N-methylpropionamide
Similarity: 0.92
[ 64214-66-0 ]
4-Chloro-N-methoxy-N-methylbutanamide
Similarity: 0.76
[ 67442-07-3 ]
2-Chloro-N-methoxy-N-methylacetamide
Similarity: 0.62
[ 113778-69-1 ]
N-Methoxy-N-methylisobutyramide
Similarity: 0.97
[ 104863-65-2 ]
N-Methoxy-N-methylpropionamide
Similarity: 0.92
[ 147356-78-3 ]
N-Methoxy-N-methylcyclopropanecarboxamide
Similarity: 0.88
[ 215950-19-9 ]
N-Methoxy-N,1-dimethylpiperidine-4-carboxamide
Similarity: 0.82
[ 113778-69-1 ]
N-Methoxy-N-methylisobutyramide
Similarity: 0.97
[ 104863-65-2 ]
N-Methoxy-N-methylpropionamide
Similarity: 0.92
[ 147356-78-3 ]
N-Methoxy-N-methylcyclopropanecarboxamide
Similarity: 0.88
[ 215950-19-9 ]
N-Methoxy-N,1-dimethylpiperidine-4-carboxamide
Similarity: 0.82